Alyeska reports 5.93% stake in Kindly MD

Rhea-AI Filing Summary

Alyeska Investment Group and related parties have disclosed a significant passive stake in Kindly MD, Inc. According to this Schedule 13G, Alyeska Investment Group, L.P., Alyeska Fund GP, LLC, and Anand Parekh beneficially own 25,612,676 shares of Kindly MD common stock.

This position represents 5.93% of Kindly MD’s outstanding common shares, based on 431,653,091 shares outstanding as reported in the company’s Form 8-K filed on December 18, 2025. The filers certify that the shares were acquired and are held in the ordinary course of business, without the purpose or effect of changing or influencing control of the company.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What ownership stake in Kindly MD (NAKA) does Alyeska report in this Schedule 13G?

Alyeska and related reporting persons report beneficial ownership of 25,612,676 Kindly MD common shares, representing 5.93% of the company’s outstanding stock. This percentage is calculated using 431,653,091 shares outstanding, as disclosed in Kindly MD’s Form 8-K on December 18, 2025.

Who are the reporting persons on the Kindly MD (NAKA) Schedule 13G filing?

The reporting persons are Alyeska Investment Group, L.P., Alyeska Fund GP, LLC, and Anand Parekh. All three share voting and dispositive power over 25,612,676 Kindly MD common shares, with no sole voting or dispositive authority reported for any of them individually.

Is Alyeska’s stake in Kindly MD (NAKA) reported as a passive investment?

Yes. The filing certifies the shares were acquired and are held in the ordinary course of business and not for the purpose or effect of changing or influencing control of Kindly MD, consistent with a passive investment reported on Schedule 13G.

How is Alyeska’s 5.93% ownership in Kindly MD (NAKA) calculated?

The 5.93% figure is based on 25,612,676 shares beneficially owned divided by 431,653,091 outstanding shares of Kindly MD common stock. The outstanding share count comes from Kindly MD’s Form 8-K filed with the SEC on December 18, 2025.

What voting and dispositive powers does Alyeska report over Kindly MD (NAKA) shares?

The reporting persons disclose shared voting power over 25,612,676 shares and shared dispositive power over the same number of shares. They report no sole power to vote or to dispose of any Kindly MD common shares individually.

When did the ownership event triggering this Kindly MD (NAKA) Schedule 13G occur?

The date of the event requiring this Schedule 13G filing is December 31, 2025. This date marks when the reporting persons’ beneficial ownership position reached the level that triggered the obligation to report under SEC beneficial ownership rules.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/17/2026 - 04:45 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Kindly MD, Inc.

(Name of Issuer)

Common Stock, par value $0.001

(Title of Class of Securities)

49457M106

(CUSIP Number)

12/31/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 49457M106

1

Names of Reporting Persons

Alyeska Investment Group, L.P.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 25,612,676.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 25,612,676.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

25,612,676.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.93 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

CUSIP No. 49457M106

1

Names of Reporting Persons

Alyeska Fund GP, LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 25,612,676.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 25,612,676.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

25,612,676.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.93 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

CUSIP No. 49457M106

1

Names of Reporting Persons

Anand Parekh

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 25,612,676.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 25,612,676.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

25,612,676.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.93 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Kindly MD, Inc.
(b)	Address of issuer's principal executive offices: 5097 South 900 East, Suite 100, Salt Lake City, UT 84117
Item 2.
(a)	Name of person filing: (i) Alyeska Investment Group, L.P. (ii) Alyeska Fund GP, LLC (iii) Anand Parekh
(b)	Address or principal business office or, if none, residence: (i) 77 West Wacker Drive, 7th Floor, Chicago, IL 60601 (ii) 77 West Wacker Drive, 7th Floor, Chicago, IL 60601 (iii) 77 West Wacker Drive, 7th Floor, Chicago, IL 60601
(c)	Citizenship: (i) Alyeska Investment Group, L.P. - Delaware (ii) Alyeska Fund GP, LLC - Delaware (iii) Anand Parekh - United States of America
(d)	Title of class of securities: Common Stock, par value $0.001
(e)	CUSIP No.: 49457M106
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 25,612,676
(b)	Percent of class: 5.93%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 0
	(ii) Shared power to vote or to direct the vote: 25,612,676
	(iii) Sole power to dispose or to direct the disposition of: 0
	(iv) Shared power to dispose or to direct the disposition of: 25,612,676
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Alyeska Investment Group, L.P.

Signature:	Jason Bragg
Name/Title:	Jason Bragg | Chief Financial Officer
Date:	02/17/2026

Alyeska Fund GP, LLC

Signature:	Jason Bragg
Name/Title:	Jason Bragg | Chief Financial Officer
Date:	02/17/2026

Anand Parekh

Signature:	Anand Parekh
Name/Title:	Anand Parekh | Self
Date:	02/17/2026

Exhibit Information

The reporting persons are the beneficial owners of 25,612,676 common shares of the Issuer. The percentage of beneficial ownership is based on 431,653,091 shares of the registrant's common stock outstanding as reported on the Issuer's Form 8-K filed with the Securities and Exchange Commission on December 18, 2025. JOINT FILING STATEMENT PURSUANT TO RULE 13d-1(k) The undersigned acknowledge and agree that the foregoing statement on SCHEDULE 13G, is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on SCHEDULE 13G, shall be filed on behalf of each of the undersigned without the necessity of filing additional joint acquisition statements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows or has reason to believe that such information is inaccurate.